medigraphic.com
Órgano Oficial del Instituto Nacional de Pediatría

2017, Number 1

<< Back Next >>

Acta Pediatr Mex 2017; 38 (1)

Conditions related with the development of septae in the abdominal cavity of pediatric patients in peritoneal dialysis

Patiño-García G, Sepúlveda-Hernández MT, Martínez-Sagredo EJ, Barrerade León JC

Language: Spanish
References: 14
Page: 17-25
PDF size: 614.57 Kb.


ABSTRACT

Background: At our hospital, peritoneal dialysis is a first-instance renal substitution method. Septae in the abdominal cavity of children with renal insufficiency comprise complications for repeated manifestations of peritonitis.
Objetive: To determine conditions related with the development of septae in the abdominal cavity of pediatric patients with peritoneal dialysis.
Material and Method: Observational retrospective study from March 2012 to October 2014 that included pediatric patients with chronic renal disease with peritoneal dialysis. The presence of septae was determined by abdominal UltraSound (US). Inferential statistics with Fisher exact test and Mann–Whitney U, risk association with Odds Ratio (OR). Sixty patients in two groups: the group with septae n=20, and the group without septae n=40. Masculine gender n=11 (55%) vs. n=25 (62%): age (years), median 8 years (range, 0.5–15 years) vs. 9 years (range, 0.5–16) p=0.756; median dialysis duration 12 months (range, 4–60 months) vs. 16 months (range, 2–81 months) p=0.653.
Results: Etiology of undetermined renal insufficiency n=13 (65%) vs. n=25 (62%), and related factors: hyperosmolar glycosylated solution n=5 (25%) vs. n=11 (28%) p=0.917; abdominal surgery after Tenckoff n=3 (15%) vs. n=7 (18%); clinical manifestations of peritonitis n=20 (100%) vs. n=29 (72%) p=0.025, and systemic treatment n=19 (95%) vs. n=22 (55%) in the groups with and without septae (p=0.004).
Conclusions: Number of events of peritonitis and systemic treatment are factors related with the development of abdominal septae in children with chronic renal insufficiency in peritoneal dialysis.


REFERENCES

  1. López-Cervantes M, Rojas Rusell ME, Tirado-Gómez CL, Durán-Arenas L, Pacheco-Domínguez RL, Venado-Estrada AA, et al. Enfermedad renal crónica y su atención mediante tratamiento sustitutivo en México. México DF: Facultad de Medicina, Universidad Autónoma de México. 2010:19-38.

  2. Méndez-Durán A, Méndez-Bueno JF, Tapia-Yañez T, Miñoz-Montes A, Aguilar-Sánchez L. Epidemiología de la insuficiencia renal crónica en México. Dial Traspl. 2010;31:7-11.

  3. Sandi MS, Romay NM, Ríos CN, Kuszmiruk AC. Diálisis peritoneal: Complicaciones más frecuentes. Revista de posgrado de la VI cátedra de Medicina. 2010;199:16-21.

  4. Rabindranath KS, Adams J, Ali TZ, Daly C, Vale L, Macleod AM. Automated vs continuous ambulatory peritoneal dialysis: a systematic review of randomized controlled trials. Nephrol Dial Transplant. 2007;22:2991-8.

  5. Morales Aguirre JJ, Aguelles Guerrero AG. Peritonitis secundaria a diálisis en pacientes con insuficiencia renal crónica: reporte de seis años en un hospital de tercer nivel. Bol Med Hosp Infant Mex. 2007;64:221-230.

  6. Fernández-Villa-Fernández A, Reguera-Álvarez R, González- Díaz I. Esclerosis peritoneal: análisis de dos casos. Rev Soc Esp Enferm Nefrol. 2009;12:164-166.

  7. Hendriks MP, de Sevaux RG, Hilbrands LB. Encapsulating peritoneal sclerosis in patients on peritoneal dialysis. Neth J Med. 2008;66:269-74.

  8. Kawanishi H, Moriishi M. Encapsulating Peritoneal Sclerosis: Prevention and treatment. Perit Dial. Int. 2007;27:S289-92.

  9. Merkle M, Wornle M. Sclerosis peritonitis: A rare but fatal complication of peritoneal inflammation. Mediators Inflamm. 2012;2012:1-4.

  10. Soriano-Cabrera S. Definición y clasificación de los estadios de la enfermedad renal crónica. Prevalencia claves para el diagnóstico precoz. Factores de riesgo de enfermedad renal crónica. Nefrología. 2004;24(S6):27-34.

  11. Kawanishi H. The pathogenesis and therapeutic option of encapsulating peritoneal sclerosis. Int J Artif Organs. 2005;28:150-5.

  12. Kawanishi H. Encapsulating peritoneal sclerosis. Nephrology 2005;10:249-55.

  13. Barrera P, Zambrano P, Contreras A, Dreves P, Salgado I, Vogel A, Encalada R, Cano F. Complicaciones infecciosas en diálisis peritoneal crónica. Rev Chil Pediatr. 2008;79:522-536.

  14. Warady B. Consensus guidelines for the treatment of peritonitis in pediatric patients receiving peritoneal dialysis. Perit Dial Int. 2000;20(6):610-24.




2020     |     www.medigraphic.com